Solid-State NMR Structures of Phospholamban or Sarcolipin Bound to Calcium ATPase (SERCA) Reveal the Mode of Inhibition  by Vostrikov, Vitaly V. et al.
Tuesday, February 18, 2014 585aand SLN can bind to the same groove but interact with a different set of resi-
dues on SERCA. These data collectively suggest that SLN is functionally
distinct from PLB; its ability to interact with SERCA in the presence of
Ca2þ causes uncoupling of the SERCA pump and increased heat production.
2955-Pos Board B647
Solid-State NMR Structures of Phospholamban or Sarcolipin Bound to
Calcium ATPase (SERCA) Reveal the Mode of Inhibition
Vitaly V. Vostrikov, Kaustubh R. Mote, Martin Gustavsson, Gopinath Tata,
Alessandro Cembran, Gianluigi Veglia.
University of Minnesota, Minneapolis, MN, USA.
Sarco(endo)plasmic reticulum calcium ATPase (SERCA) transports Ca2þ ions
against a concentration gradient from cytoplasm to sarcoplasmic reticulum,
initiating muscle relaxation. SERCA activity is regulated by two single-span
membrane proteins: phospholamban (PLN) or sarcolipin (SLN). Although
the recent crystal structures offered a prime view of these complexes
(SERCA/SLN and SERCA/PLN), the mechanism of regulation is still un-
known. Here, we used a combination of oriented and magic angle spinning
(MAS) solid-state NMR spectroscopy to gain atomistic level insights into the
mechanism of regulation of SERCA by both PLN and SLN in fully hydrated
lipid bilayer membranes.
To map protein-protein interactions within lipid membranes, we designed
innovative labeling strategies involving various combinations of isotopic
labeling schemes, paramagnetic probes, and thioalkylation of SERCA’s cys-
teines. The restraints obtained from the experimental data were used to model
the complexes which were further refined using restrained molecular dy-
namics simulations in explicit lipid bilayers. The structures of SERCA in
complex with PLN or SLN provide a detailed view of the binding interface
and shed light on the mechanism of SERCA regulation (i.e., inhibition and
activation). Knowledge of the biophysical basis of SERCA regulation offers
unprecedented opportunity for the rational design of the mutants for gene
therapy. We expect the approach and methods used by us to be generally
applicable for mapping protein-protein interactions in membrane protein
complexes larger than 100 kDa, which are typically inaccessible to other
experimental methods.
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On a cellular level, the cardiac cycle is orchestrated by release of Ca2þ into
the cytosol during systole (contraction) and subsequent reuptake of Ca2þ
into internal stores by an ion-motive ATPase during diastole (relaxation).
This pump, the sarco(endo)plasmic reticulum calcium ATPase (SERCA), un-
dergoes large conformational changes between enzymatic substates during
calcium transport. Recently, we quantified SERCA structural dynamics using
intramolecular fluorescence resonance energy transfer (FRET). Here, we
extend this work to investigate SERCA conformational changes in atomic
detail using molecular dynamics simulations. Specifically, we tested a hypoth-
esis generated from FRET experiments: Open conformations of SERCA are
more dynamic than compact, closed structures. Our molecular dynamics sim-
ulations showed that larger amplitude cytoplasmic domain motions for open
conformations compare to compact structures. The data suggest that the
open conformation of SERCA is more dynamically disordered than the closed
state. We also performed a molecular dynamics simulation on PLB, a homo-
pentameric regulator of SERCA. Previous studies have suggested that a natu-
rally occurring human heart failure mutation of PLB, L39Stop, disrupts
membrane localization. Molecular dynamics simulations showed that
L39Stop-PLB was unstable compared to WT PLB. In particular, we observed
that the interactions between protomers of the L39Stop PLB pentamer were
disrupted within 10 ns, resulting in collapse of the pentamer structure.
L39Stop-PLB monomers were subsequently extruded from the bilayer,
becoming soluble in the aqueous phase. We determined that the instability
of the L39Stop PLB pentamers is partially due to lack of van der Waals in-
teractions between truncated PLB monomers.
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Phospholamban (PLB) regulates the activity of the cardiac Ca pump
(SERCA2a). The molecular mechanism by which PLB inhibits SERCA2a
activity involves physical binding of PLB to the Ca-free, E2 conformation
of the enzyme, specifically, formation of E2PLB, which prevents Ca bindingto SERCA2a. To test how different PLB mutants competitively interact with
E2, we examined the ability of a gain-of-function, cross-linkable PLB
mutant, N27A,N30C,L37A-PLB (PLB3) to inhibit Ca-ATPase activity and
to cross-link to the PLB-tethered pump (SER-20G-PLB) after co-expressing
the two proteins in insect cells. SER-20G-PLB, a chimeric WT-SERCA2a-
WT-PLB construct, retains a fully catalytic active Ca-pump and an intrinsi-
cally regulatory, flexibly anchored PLB-tether. SER-20G-PLB exhibited a
rightward-shifted Ca-dependent ATPase activity curve (KCa=0.26 5 0.03
mM), compared to that of WT-SERCA2a expressed alone (KCa=0.15 5
0.02 mM). Co-expressed PLB3 super-inhibited the WT-PLB-tethered enzyme,
further shifting the Ca-dependent ATPase activity curve to the right
(KCa=0.66 5 0.08 mM). Further, in the Ca-free condition, PLB3 cross-
linked to K328 of SER-20G-PLB at the cytoplasmic extension of M4. Impor-
tantly, the cross-linking was completely inhibited by micromolar Ca and the
SERCA inhibitor tharpsigargin. The Ki values for Ca-dependent inhibition
of PLB3 cross-linking to the tethered pump was 0.9 5 0.1 mM, similar
to that obtained using samples with co-expression of PLB3 and WT-
SERCA2a. A similar gain-of-function mutant N27A,L37A,V49C-PLB, also
super-inhibited the tethered pump, and cross-linked to V89C-SER-20G-PLB
at the C-terminal end of transmembrane domain M2. These results demon-
strate that freely diffusing, gain-of-function PLB mutants completely replace
the WT-PLB-tether and must fit into the binding pocket previously occupied
by WT-PLB. Thus, there is a reversible equilibrium between different PLB
mutants and WT-PLB for binding to E2, in which PLB mutants possessing
higher binding affinity for SERCA2a produce more stable E2PLB and lower
Ca affinity.
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We have studied the differential effects of phospholamban (PLB) phosphory-
lation states on the activity of the sarcoplasmic reticulum (SR) Ca2þ-ATPase
(SERCA). It is known that PLB inhibits SERCA and that PLB phosphorylation
at S16 and/or T17 relieves this inhibition in cardiac SR. However, the func-
tional effects of the two PLB phosphorylation sites have not been compared
quantitatively. Therefore, we co-reconstituted SERCA1a with synthetic
PLB, pS16-PLB, pT17-PLB, or pS16/pT17-PLB in phospholipid vesicles
and measured Ca2þ-dependent SERCA ac-
tivity. Inhibition was maximally relieved
by phosphorylation at S16, followed by
doubly phosphorylated PLB (pS16/pT17-
PLB) and pT17-PLB. Thus, T17 phosphor-
ylation shows the least capacity for
SERCA inhibition relief, and actually de-
creases the effect of S16 phosphorylation
on the same PLB. Quantitative Western
blots were used to demonstrate that all
four PLB phosphorylation states are pre-
sent in cardiac SR. Cardiac SR was treated
with PLB antibodies and protein kinase A
(PKA) to quantify the effects of PLB phos-
phorylation states on SERCA inhibition in
a biological milieu. These results show that
each PLB phosphorylation state uniquely
alters Ca2þ homeostasis. These effects are
relevant to cardiovascular health, disease
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Cardiac muscle contraction is regulated through the release and reuptake of
Ca2þ from the sarcoplasmic reticulum (SR), with the SR Ca2þ-ATPase
(SERCA) inducing relaxation by restoring Ca2þ to the SR lumen from the
cytosol. SERCA is regulated by the single-pass membrane protein phospho-
lamban (PLB), which acts as inhibitor unless phosphorylated at Ser16. The
mechanism of SERCA-PLB regulation remains poorly understood, though
our recent work demonstrated that PLB remains bound to SERCA following
Ser16 phosphorylation, indicating that a structural rearrangement mediates
